A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020–2021
Snydman, D. R., McDermott, L. A., Thorpe, C. M., Goldstein, E. J. C., Schuetz, A. N., Johnson, S., Gerding, D. N., Gluck, L., Bourdas, D., Carroll, K. C., Lancaster, C. K., Garey, K. W., Wang, Q., Walk, S. T., Duperchy, E.
Published in Antimicrobial agents and chemotherapy (18.10.2023)
Published in Antimicrobial agents and chemotherapy (18.10.2023)
Get full text
Journal Article